Indications
Celsentri, in combination with other antiretroviral medicinal products, is indicated for treatment experienced adults, adolescents and children of 2 years of age and older and weighing at least 10 kg infected with only CCR5-tropic HIV-1 detectable
Composition
- Active substance
- maraviroc
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Celsentri
- Active substance
- maraviroc
- ATC code
- J05AX09
- Therapeutic area
- HIV Infections
- Marketing authorisation holder
- ViiV Healthcare B.V.
- Status
- Authorised